-+ 0.00%
-+ 0.00%
-+ 0.00%

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. COMPLETES ENROLLMENT IN FDA-CLEARED ADAPT TRIAL FOR CELZ-201-OLASTROCEL, MARKING MAJOR CLINICAL INFLECTION POINT

Reuters·12/17/2025 14:15:00

Please log in to view news